News

Shares of app-based education company Duolingo (NASDAQ: DUOL) soared on Thursday, following the release of its financial results for the third quarter of 2023. Results surpassed Wall Street's

Pull up a stock chart for Walt Disney (NYSE: DIS). Go back nearly six months to May 10, 2023. It's the last time that shares of the media giant traded in the triple digits. It's been a frustrating

2022 was a tough year for the stock market. Even though broader market indexes have risen in 2023, plenty of companies are still struggling to get their share prices back to where they were during

Last year, the Federal Reserve began hiking interest rates in an effort to slow down the economy. Today, interest rates are at their highest levels since the early 2000s. For many businesses, an

In this video, I will talk about Fiverr's (NYSE: FVRR) third-quarter earnings report and explain how the business is navigating an unpredictable environment while also releasing new useful tools for

Whether you own a stock or are just contemplating a purchase, it can be a useful exercise sometimes to review whether it makes sense to buy, hold, or sell the shares -- especially when a company is

E-commerce giant Shopify (NYSE: SHOP) surprised investors and analysts earlier this year when it decided to ditch its logistics business even though management had repeatedly emphasized its

Image source: The Motley Fool.

Li Auto (NASDAQ: LI)Q3 2023 Earnings CallNov 09, 2023, 7:00 a.m. ET

Operator

Continue reading

Source Fool.com

Investing in biotech stocks is risky. And one of the more volatile ones of late is Sarepta Therapeutics (NASDAQ: SRPT). Shares of the company crashed last week after it released results from phase 3

Biotech giant Regeneron (NASDAQ: REGN) and streaming specialist Roku (NASDAQ: ROKU) have been solid performers for most of the year, but both stocks recently jumped following their third-quarter

While it's probably representative of how big a financial geek I am, opening a custodial account for my eight-year-old daughter has been a surprisingly fun and fulfilling experience. Whether she

Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) are locked in an intensifying conflict for control over the markets for weight loss and type 2 diabetes treatments. Novo Nordisk's diabetes therapy

Unlike the Android smartphone market that's starting to bottom out, Apple (NASDAQ: AAPL) products are still in a bit of a downturn. Sure, the iPhone 15 looks like a hit, and MacBook demand is

It's been a tough past three years for most of China's stocks. Alibaba (NYSE: BABA) has been no exception. Shares of the e-commerce company soared during and because of the COVID-19 pandemic. Then

Investors continued to find the stock market attractive on Thursday morning, even in the wake of several days of significant gains. After having spent so much of the year being pessimistic about the

Walgreens Boots Alliance (NASDAQ: WBA) has struggled with growth over the years. That issue has trickled down to the bottom line as well and profits also haven't been great. To help resolve this

Palantir Technologies (NYSE: PLTR) and SoundHound AI (NASDAQ: SOUN) represent two different ways to invest in the booming artificial intelligence (AI) market. Palantir's platforms help government

After its dim third-quarter earnings report on Nov. 2, Moderna (NASDAQ: MRNA) saw its shares crash by more than 12% before recovering. Still, the stock is down by 60% this year, and it's clear that

Weight-loss medications are back in the headlines. In particular, Novo Nordisk (NYSE: NVO) stands to gain tremendously as the maker of instant-classic obesity therapy Wegovy as well as the type 2

Palantir Technologies (NYSE: PLTR) stock was in raging form on the market Nov. 2 following the release of its third-quarter results -- and as it became clear that the company's growth is set to